Close
Nordic 9Nordic 9

Avoro Capital (investor - Venture Capital)

United States avorocapital.com
See something wrong or missing? Let us know
Offices:New York

Avoro Capital Advisors is a global life sciences investment firm with a focus on supporting emerging biotechnology companies.

Average round investment:155.73M USD
Average number per year:1.0
Distribution: 2025 (1)2021 (1)
Portfolio companies: Denmark HemabDenmark IO Biotech
Mostly invests in: Denmark Denmark (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Avoro Capital

Name Criteria
United States Adjuvant Capital
60%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Bristol-Myers Squibb
60%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Denmark LF Investments
60%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States RA Capital Management
60%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Sanofi Ventures
60%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland HBM Healthcare Investments
57%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Boxer Capital
56%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Cormorant Asset Management
56%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States EcoR1 Capital
56%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Famille C Invest
56%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top